Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

NOREPINEPHRINE BITARTRATE INJECTION USP DIN 02485680

Status: Dormant
Holder: GENERIC MEDICAL PARTNERS INC
Molecule: NOREPINEPHRINE (NOREPINEPHRINE BITARTRATE)
Available to quote

Health Canada record

Active ingredient(s)NOREPINEPHRINE (NOREPINEPHRINE BITARTRATE) 1 MG
Dosage formSolution
RouteIntravenous
ScheduleETHICAL
ClassHuman
ATCC01CA03 NOREPINEPHRINE
Original market date04-May-2020
Current status date22-Jul-2026
SourceHealth Canada DPD

Establishment licence of the holder

Generic Medical Partners Inc — licence 101749, currently licensed, last inspection rating C (2023-05-08).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing NOREPINEPHRINE (NOREPINEPHRINE BITARTRATE)

DINProductCompanyFormStrengthStatus
02501430NOREPINEPHRINE BITARTRATE IN 5% DEXTROSE INJECTIONBAXTER CORPORATIONSolutionNOREPINEPHRINE (NOREPINEPHRINE BITARTRATE) 0.016 MGMarketed
02501449NOREPINEPHRINE BITARTRATE IN 5% DEXTROSE INJECTIONBAXTER CORPORATIONSolutionNOREPINEPHRINE (NOREPINEPHRINE BITARTRATE) 0.032 MGMarketed
02540630NOREPINEPHRINE BITARTRATE INJECTIONJUNO PHARMACEUTICALS CORP.SolutionNOREPINEPHRINE (NOREPINEPHRINE BITARTRATE) 1 MGMarketed
02538857NOREPINEPHRINE BITARTRATE INJECTIONAS KALCEKSSolutionNOREPINEPHRINE (NOREPINEPHRINE BITARTRATE) 1 MGApproved
00893285NOREPINEPHRINE BITARTRATE INJECTION USPSANDOZ CANADA INCORPORATEDSolutionNOREPINEPHRINE (NOREPINEPHRINE BITARTRATE) 1 MGMarketed
02358743NOREPINEPHRINE BITARTRATE INJECTION, USPSTERIMAX INCSolutionNOREPINEPHRINE (NOREPINEPHRINE BITARTRATE) 1 MGMarketed
02241981LEVOPHEDPFIZER CANADA ULCSolutionNOREPINEPHRINE (NOREPINEPHRINE BITARTRATE) 1 MGCancelled Post Market
02017679LEVOPHED LIQ IV 1.0MG/MLSANOFI CANADA, INC.LiquidNOREPINEPHRINE (NOREPINEPHRINE BITARTRATE) 1 MGCancelled Post Market
Request a quote for NOREPINEPHRINE BITARTRATE INJECTION USP

How to read a Canadian DIN record